Which of the following drugs used as nail lacquer belongs to morpholines?

Explanation

## Correct Answer: B. Amorolfine Amorolfine is the only morpholine antifungal agent among the options. Morpholines are a distinct chemical class of antifungal drugs that work by inhibiting **Δ14-reductase and Δ8→Δ7-isomerase** in the fungal sterol synthesis pathway, disrupting ergosterol production and causing fungal cell membrane damage. Amorolfine is specifically formulated as a **nail lacquer (5% solution)** and is the gold standard topical agent for onychomycosis in India, particularly for mild-to-moderate nail involvement. It penetrates the nail plate effectively and achieves high local concentrations. The morpholine class is distinct from azoles (which inhibit lanosterol 14α-demethylase) and allylamines (which inhibit squalene epoxidase). Amorolfine's unique mechanism and superior nail penetration make it ideal for topical nail therapy. In Indian clinical practice, amorolfine lacquer is preferred for early-stage onychomycosis and as adjunctive therapy with systemic agents in advanced cases, as per IAP guidelines on dermatophyte infections. ## Why the other options are wrong **A. Ciclopirox olamine** — Ciclopirox olamine is a **hydroxypyridone** (not a morpholine), though it is also available as a nail lacquer formulation. It works via a different mechanism—chelation of metal ions (Fe³⁺, Zn²⁺) in fungal enzymes—rather than sterol synthesis inhibition. While effective for onychomycosis, it belongs to a separate chemical class and is not a morpholine. **C. Oxiconazole** — Oxiconazole is an **imidazole antifungal** (not a morpholine), which inhibits lanosterol 14α-demethylase in the azole pathway. Although it can be used topically for dermatophyte infections, it is not formulated as a nail lacquer and does not belong to the morpholine class. This is a common NBE trap pairing azoles with nail therapy. **D. Tioconazole** — Tioconazole is a **triazole antifungal** (not a morpholine), which also inhibits fungal lanosterol 14α-demethylase. Although it has been used topically for nail infections in some formulations, it is not a morpholine and is not the standard nail lacquer choice in Indian practice. Azoles are a separate class with a different mechanism. ## High-Yield Facts - **Amorolfine** is the only morpholine antifungal available as a nail lacquer (5% solution) in India. - Morpholines inhibit **Δ14-reductase and Δ8→Δ7-isomerase**, disrupting ergosterol synthesis—distinct from azole and allylamine mechanisms. - **Nail lacquer application**: twice weekly for 6–12 months; requires complete nail replacement for cure in onychomycosis. - Amorolfine achieves **high local nail concentrations** with minimal systemic absorption, making it safe for monotherapy in mild-to-moderate nail disease. - In India, amorolfine is preferred for **early onychomycosis** and as adjunctive therapy with terbinafine or itraconazole in advanced cases (IAP guidelines). ## Mnemonics **MORPHO = Amorolfine Only** **M**orpholine = **A**morolfine (the only morpholine nail lacquer). All other topical antifungals (azoles, hydroxypyridones, allylamines) use different mechanisms and are not morpholines. **Nail Lacquer Agents in India** **A**morolfine (morpholine) and **C**iclopirox (hydroxypyridone) are the two main nail lacquers; amorolfine is morpholine, ciclopirox is not. ## NBE Trap NBE pairs azoles (oxiconazole, tioconazole) with nail therapy to lure students who know these are topical antifungals but confuse chemical class with formulation type. The question tests whether you know the specific morpholine class, not just that a drug treats nails. ## Clinical Pearl In Indian dermatology practice, amorolfine lacquer is the first-line topical agent for onychomycosis affecting <50% of the nail plate. Patients apply it twice weekly and must file away the infected nail debris weekly—compliance is key. For extensive disease, it is combined with oral terbinafine to accelerate cure and prevent relapse. _Reference: KD Tripathi Pharmacology Ch. 52 (Antifungals); Robbins Pathologic Basis of Disease Ch. 25 (Fungal Infections)_